These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34336894)

  • 21. Rabeprazole: an update of its use in acid-related disorders.
    Carswell CI; Goa KL
    Drugs; 2001; 61(15):2327-56. PubMed ID: 11772142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of short-term proton pump inhibitor plus anti-ulcer drug on the healing of endoscopic submucosal dissection-derived artificial ulcer: a randomized controlled trial.
    Nakamura M; Tahara T; Shiroeda H; Matsunaga K; Otsuka T; Yonemura J; Shibata T; Arisawa T
    Hepatogastroenterology; 2015; 62(137):219-24. PubMed ID: 25911899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer--a European multicentre study. The European Rabeprazole Study Group.
    Dekkers CP; Beker JA; Thjodleifsson B; Gabryelewicz A; Bell NE; Humphries TJ
    Aliment Pharmacol Ther; 1998 Aug; 12(8):789-95. PubMed ID: 9726393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postmarketing surveillance of rabeprazole in upper gastrointestinal peptic lesions in Japanese patients with coexisting hepatic disorders.
    Makino I; Nakamura K; Sato Y; Sato Y; Sezai S; Ikeda Y; Shinmura W; Watahiki H; Yamamoto H; Hioki Y; Suzuki M; Kumada T; Honda T; Rikitoku T; Hisanaga Y; Fukui H; Yamao J; Kawasaki H; Hosoda A; Onji M; Matsui H; Sata M; Torimura T; Oho K; Maekawa R; Takagi Y; Shakado S; Nakayama M; Gondo K; Fukushima H; Kusaba T; Tsubouchi H; Hayashi K; Hori T; Iida Y; Yutoku K; Maetani N; Kubo Y; Miyata Y
    Curr Ther Res Clin Exp; 2006 Jan; 67(1):1-20. PubMed ID: 24678081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Standard-Dose Proton Pump Inhibitors in the Initial Non-eradication Treatment of Duodenal Ulcer: Systematic Review, Network Meta-Analysis, and Cost-Effectiveness Analysis.
    Zhang J; Ge L; Hill M; Liang Y; Xie J; Cui D; Li X; Zheng W; He R
    Front Pharmacol; 2018; 9():1512. PubMed ID: 30666204
    [No Abstract]   [Full Text] [Related]  

  • 26. Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China.
    Xie Y; Zhu Z; Wang J; Zhang L; Zhang Z; Lu H; Zeng Z; Chen S; Liu D; Lv N;
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients have treatment preferences: a multicentre, double-blind, crossover study comparing rabeprazole and omeprazole.
    Johnson M; Guilford S; Libretto SE;
    Curr Med Res Opin; 2002; 18(5):303-10. PubMed ID: 12240793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ilaprazole for the treatment of duodenal ulcer: a randomized, double-blind and controlled phase III trial.
    Wang L; Zhou L; Hu H; Lin S; Xia J
    Curr Med Res Opin; 2012 Jan; 28(1):101-9. PubMed ID: 22070512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomised clinical trial: rabeprazole plus aspirin is not inferior to rabeprazole plus clopidogrel for the healing of aspirin-related peptic ulcer.
    Luo JC; Huang KW; Leu HB; Chen LC; Hou MC; Li CP; Lu CL; Lin HC; Lee FY; Lee SD
    Aliment Pharmacol Ther; 2011 Sep; 34(5):519-25. PubMed ID: 21726257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study.
    Kinoshita Y; Kato M; Fujishiro M; Masuyama H; Nakata R; Abe H; Kumagai S; Fukushima Y; Okubo Y; Hojo S; Kusano M
    J Gastroenterol; 2018 Jul; 53(7):834-844. PubMed ID: 29188387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The short term effect of rabeprazol versus omeprazole on symptom relief of duodenal ulcer].
    Lin S;
    Zhonghua Nei Ke Za Zhi; 2002 Sep; 41(9):589-91. PubMed ID: 12421488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Quadruple regimens using domestically manufactured drugs in gastritis and duodenal ulcer patients for Helicobacter pylori eradication: a perspective, multicenter, randomized controlled trial].
    Gao W; Hu F; Cheng H; Wang H; Yang Y; Liang H; Zhang S; Meng F; Cui M; Wei H; Sheng J; An HJ; Jiang B; Chen Y; Li Y; Zuo X; Gong J; Zhao P; Dong L; Wang B; Jiang K; Zhang G; Li J; Zhao Y; Gao H; Yang L
    Zhonghua Yi Xue Za Zhi; 2016 Jan; 96(4):260-4. PubMed ID: 26879784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of four proton pump inhibitors for the short-term treatment of esophagitis in elderly patients.
    Pilotto A; Franceschi M; Leandro G; Scarcelli C; D'Ambrosio LP; Paris F; Annese V; Seripa D; Andriulli A; Di Mario F
    World J Gastroenterol; 2007 Sep; 13(33):4467-72. PubMed ID: 17724802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vonoprazan is Superior to Rabeprazole for Healing Endoscopic Submucosal Dissection: Induced Ulcers.
    Yamasaki A; Yoshio T; Muramatsu Y; Horiuchi Y; Ishiyama A; Hirasawa T; Tsuchida T; Sasaki Y; Fujisaki J
    Digestion; 2018; 97(2):170-176. PubMed ID: 29310111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic review: standard- and double-dose proton pump inhibitors for the healing of severe erosive oesophagitis -- a mixed treatment comparison of randomized controlled trials.
    Edwards SJ; Lind T; Lundell L; DAS R
    Aliment Pharmacol Ther; 2009 Sep; 30(6):547-56. PubMed ID: 19558609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of 7-day rabeprazole- and omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease.
    Hawkey CJ; Atherton JC; Treichel HC; Thjodleifsson B; Ravic M
    Aliment Pharmacol Ther; 2003 Apr; 17(8):1065-74. PubMed ID: 12694089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective randomized trial of a potassium competitive acid blocker vs proton pump inhibitors on the effect of ulcer healing after endoscopic submucosal dissection of gastric neoplasia.
    Komori H; Ueyama H; Nagahara A; Akazawa Y; Takeda T; Matsumoto K; Matsumoto K; Asaoka D; Hojo M; Yao T; Watanabe S
    J Int Med Res; 2019 Apr; 47(4):1441-1452. PubMed ID: 30816056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis.
    Robinson M; Fitzgerald S; Hegedus R; Murthy A; Jokubaitis L;
    Aliment Pharmacol Ther; 2002 Mar; 16(3):445-54. PubMed ID: 11876697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic efficacy and safety of Kangfuxin in combination with rabeprazole in the treatment of peptic ulcer: A systematic review and meta-analysis.
    Lin M; Zhang S; Zhang M; Shi J; Zhang C; Luo R; You J; Sun J; Zhang J; Gao F
    Medicine (Baltimore); 2020 Nov; 99(48):e23103. PubMed ID: 33235070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.